187 related articles for article (PubMed ID: 29170424)
1. p300-mediated acetylation increased the protein stability of HIPK2 and enhanced its tumor suppressor function.
Choi JR; Lee SY; Shin KS; Choi CY; Kang SJ
Sci Rep; 2017 Nov; 7(1):16136. PubMed ID: 29170424
[TBL] [Abstract][Full Text] [Related]
2. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
[TBL] [Abstract][Full Text] [Related]
3. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
4. PARP1 regulates the protein stability and proapoptotic function of HIPK2.
Choi JR; Shin KS; Choi CY; Kang SJ
Cell Death Dis; 2016 Oct; 7(10):e2438. PubMed ID: 27787517
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 negatively regulates the protein stability of HIPK2.
Hwang J; Lee SY; Choi JR; Shin KS; Choi CY; Kang SJ
Biochem Biophys Res Commun; 2013 Nov; 441(4):799-804. PubMed ID: 24211575
[TBL] [Abstract][Full Text] [Related]
6. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
[TBL] [Abstract][Full Text] [Related]
7. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
[TBL] [Abstract][Full Text] [Related]
8. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.
Shima Y; Shima T; Chiba T; Irimura T; Pandolfi PP; Kitabayashi I
Mol Cell Biol; 2008 Dec; 28(23):7126-38. PubMed ID: 18809579
[TBL] [Abstract][Full Text] [Related]
9. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
11. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.
Nardinocchi L; Puca R; Givol D; D'Orazi G
FEBS Lett; 2010 Oct; 584(19):4253-8. PubMed ID: 20849851
[TBL] [Abstract][Full Text] [Related]
12. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.
Winter M; Sombroek D; Dauth I; Moehlenbrink J; Scheuermann K; Crone J; Hofmann TG
Nat Cell Biol; 2008 Jul; 10(7):812-24. PubMed ID: 18536714
[TBL] [Abstract][Full Text] [Related]
13. A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress.
de la Vega L; Grishina I; Moreno R; Krüger M; Braun T; Schmitz ML
Mol Cell; 2012 May; 46(4):472-83. PubMed ID: 22503103
[TBL] [Abstract][Full Text] [Related]
14. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.
Kim EA; Kim JE; Sung KS; Choi DW; Lee BJ; Choi CY
Biochem Biophys Res Commun; 2010 Apr; 394(4):966-71. PubMed ID: 20307497
[TBL] [Abstract][Full Text] [Related]
15. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1.
Choi DW; Seo YM; Kim EA; Sung KS; Ahn JW; Park SJ; Lee SR; Choi CY
J Biol Chem; 2008 Feb; 283(8):4682-9. PubMed ID: 18093972
[TBL] [Abstract][Full Text] [Related]
17. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
[TBL] [Abstract][Full Text] [Related]
18. Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.
Akaike Y; Kuwano Y; Nishida K; Kurokawa K; Kajita K; Kano S; Masuda K; Rokutan K
Oncogene; 2015 Jun; 34(26):3463-73. PubMed ID: 25151962
[TBL] [Abstract][Full Text] [Related]
19. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
[TBL] [Abstract][Full Text] [Related]
20. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
